J Drugs Dermatol. 2004 Jan-Feb;3(1):21-6.

Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy?

Source

Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1071, USA. jjorizzo@wfubmc.edu

Abstract

Actinic keratoses (AKs) are common dysplastic epidermal lesions that share clinical, histologic, and molecular features with squamous cell carcinoma. Therapeutic options include destructive modalities (i.e., cryosurgery, curettage) or topical fluorouracil treatment. The efficacy of topical fluorouracil for the treatment of widespread AK lesions has been demonstrated in multiple studies, but treatment is often associated with significant skin irritation. Various approaches to decrease irritation while maintaining efficacy have been attempted, including altered treatment regimens, combination therapies, and variations in vehicle formulations. Recently, a novel topical fluorouracil cream that contains 0.5% 5-fluorouracil in a microsphere vehicle has been approved for the treatment of AK. Data demonstrate that this low-dose formulation is effective in reducing AK lesions while maintaining a tolerable irritation profile.

Comment in

J Drugs Dermatol. 2004 Sep-Oct;3(5):484.

PMID:: 14964743; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Fluorouracil

LinkOut - more resources

Other Literature Sources

Molecular Biology Databases

FLUOROURACIL - HSDB

Supplemental Content

Save items

Related citations in PubMed

Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. [Clin Ther. 2002]
Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.
Loven K, Stein L, Furst K, Levy S. Clin Ther. 2002 Jun; 24(6):990-1000.
Review One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses. [Cutis. 2008]
Review One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses.
Menter A, Vamvakias G, Jorizzo J. Cutis. 2008 Jun; 81(6):509-16.
Review Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule. [Cutis. 2004]
Review Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule.
Jorizzo JL, Carney PS, Ko WT, Robins P, Weinkle SH, Werschler WP. Cutis. 2004 Dec; 74(6 Suppl):18-23.
Review Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod. [Cutis. 2003]
Review Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD, Saini R, Caglar S, Weinberg JM, Crespo J. Cutis. 2003 May; 71(5):365-70.
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. [Cutis. 2002]
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.
Weiss J, Menter A, Hevia O, Jones T, Ling M, Rist T, Roberts J, Shavin JS, Sklar J, Webster G, et al. Cutis. 2002 Aug; 70(2 Suppl):22-9.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Topical treatment of actinic keratosis with fluorouracil: is irritation associat...
Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy?
J Drugs Dermatol. 2004 Jan-Feb ;3(1):21-6.

PubMed
Circadian genes in a blind subterranean mammal III: molecular cloning and circad...
Circadian genes in a blind subterranean mammal III: molecular cloning and circadian regulation of cryptochrome genes in the blind subterranean mole rat, Spalax ehrenbergi superspecies.
J Biol Rhythms. 2004 Feb ;19(1):22-34.

PubMed
The SWI/SNF complex--chromatin and cancer.
The SWI/SNF complex--chromatin and cancer.
Nat Rev Cancer. 2004 Feb ;4(2):133-42.

PubMed
[Diagnosis and treatment of bronchiectasis].
[Diagnosis and treatment of bronchiectasis].
Ned Tijdschr Geneeskd. 2004 Jan 17 ;148(3):120-5.

PubMed
Chemical modification of the histidine residue in phospholipase A2 (Naja naja na...
Chemical modification of the histidine residue in phospholipase A2 (Naja naja naja). A case of half-site reactivity.
J Biol Chem. 1977 Apr 10 ;252(7):2405-11.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: